NDC 0023-4290

LASTACAFT

Alcaftadine

LASTACAFT is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Alcaftadine.

Product ID0023-4290_0ce7cd0a-0325-4f8a-ba9c-b9c20bbc7847
NDC0023-4290
Product TypeHuman Prescription Drug
Proprietary NameLASTACAFT
Generic NameAlcaftadine
Dosage FormSolution/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2010-11-01
Marketing CategoryNDA / NDA
Application NumberNDA022134
Labeler NameAllergan, Inc.
Substance NameALCAFTADINE
Active Ingredient Strength3 mg/mL
Pharm ClassesHistamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0023-4290-01

1 BOTTLE, PLASTIC in 1 CARTON (0023-4290-01) > 1 mL in 1 BOTTLE, PLASTIC
Marketing Start Date2010-11-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0023-4290-01 [00023429001]

LASTACAFT SOLUTION/ DROPS
Marketing CategoryNDA
Application NumberNDA022134
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-11-01

NDC 0023-4290-03 [00023429003]

LASTACAFT SOLUTION/ DROPS
Marketing CategoryNDA
Application NumberNDA022134
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2010-11-01

Drug Details

Active Ingredients

IngredientStrength
ALCAFTADINE2.5 mg/mL

OpenFDA Data

SPL SET ID:17d37e8d-7825-424b-b6ca-0a85d0bf4694
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1000085
  • 1000089
  • UPC Code
  • 0300234290032
  • Pharmacological Class

    • Histamine H1 Receptor Antagonists [MoA]
    • Histamine-1 Receptor Antagonist [EPC]
    • Histamine H1 Receptor Antagonists [MoA]
    • Histamine-1 Receptor Antagonist [EPC]

    NDC Crossover Matching brand name "LASTACAFT" or generic name "Alcaftadine"

    NDCBrand NameGeneric Name
    0023-4290LASTACAFTalcaftadine
    0023-4291LASTACAFTalcaftadine
    42254-288LASTACAFTalcaftadine

    Trademark Results [LASTACAFT]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    LASTACAFT
    LASTACAFT
    85168259 4071760 Live/Registered
    Allergan, Inc.
    2010-11-03
    LASTACAFT
    LASTACAFT
    85088422 4003795 Live/Registered
    Allergan, Inc.
    2010-07-20

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.